Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RTI International has contributed to the discovery of major drugs like camptothecin and paclitaxel/Taxol. It provides end-to-end drug development support including assay development, high-throughput screening, medicinal chemistry, preclinical formulation/PK/toxicology studies, real-world evidence generation, health economics/outcomes research (HEOR), regulatory consulting, and more. Its biomedical innovations include long-term implantable drug delivery systems under preclinical evaluation for HIV prevention/treatment and contraception. As a nonprofit CRO/research institute with global reach (~6000 staff in >75 countries), it partners with pharma/biotech/device companies as well as government agencies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RTI International.